
Clinical Research
Rescheduling Will Reprice Medical IP, Not Retail Footprints
US cannabis rescheduling is unlikely to trigger a land grab. Instead, it has the potential to reprice medical intellectual property

US cannabis rescheduling is unlikely to trigger a land grab. Instead, it has the potential to reprice medical intellectual property

Last year, as other European cannabis markets looked to be retreating from their ambitious progress in 2024, Switzerland accelerated its

On 25 September, PTMC hosted its seventh edition in central Lisbon, amid a growing sense that Portugal’s medical cannabis sector

Dutch seed bank Barney’s Farm, one of the leading names in the global consumer cannabis seeds market, has backed out